On Friday, however, Novo Nordisk announced top-line results in yet another trial. While the results don't initially sound as ...
Novo Nordisk A/S’s blockbuster drug Wegovy was targeted for price cuts by the US government and suffered a setback in a new ...
Novo Holdings, the controlling shareholder of Novo Nordisk , hopes to double the size of its recently acquired contract ...
After the Centers for Medicare & Medicaid Services announced the selection of 15 additional drugs covered under Medicare Part D for price ...
Spain — one of Europe's fastest growing economies, according to the OECD — is set to publish import and export figures on ...
After the Centers for Medicare & Medicaid Services announced the selection of 15 additional drugs covered under Medicare Part D for price negotiations – including Novo Nordisk’s (NVO ...
Novo Nordisk shares have pared some losses but ... over the company's blockbuster weight loss and diabetes drugs. JPMorgan analysts said they had previously forecast a 50% cut in prices for ...